详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Intraocular Pressure Changes After Combined Orbital Decompression and Glucocorticoid Treatment for Graves Orbitopathy

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing. [2]Aier Eye Hospital Group Co., Ltd, Beijing Aier Eye Hospital, Beijing, Jinan University, Guangzhou, Guangdong, China.

出处：

DOI：

ISSN：

关键词： Glucocorticoid treatment Graves orbitopathy iCARE intraocular pressure orbital decompression

摘要：

To evaluate the change in the intraocular pressure (IOP) in subjects with Graves orbitopathy (GO) after orbital decompression (OD) with glucocorticoids (GCs).Ninety-nine orbits of 76 patients with GO were retrospectively reviewed, with either OD (Group A), OD with intravenous glucocorticoids (i.v.GC) (Group B) or parabulbar GC (Group C) administration. The main outcome measures included pre-and post-operative IOP in the primary and upward gazes.Mean postoperative IOPs in the primary gaze were lower than the preoperative values for groups A and C (P < 0.05). The IOPs during the upward gaze were higher than those in the primary gaze before and after OD (all groups, P < 0.05). The mean postoperative and preoperative IOPs during upward gaze were similar in all groups except group C (P = 0.001). The mean decrease in IOP in the primary gaze was 1.57 ± 6.00 mm Hg and 2.22 ± 2.62 mm Hg in groups A and C, respectively (P < 0.05). Only in group C, the mean IOPs during upward gaze decrease by 5.29 ± 4.89 mm Hg (active GO before OD), and the mean gaze-related IOP decreased from 7.75 ± 6.02 to 2.57 ± 4.21 mm Hg (P < 0.05).A pbGC treatment before OD can effectively reduce the primary and upward gaze IOPs and lead to a greater postoperative reduction in the upward gaze IOP to approximate that in the primary gaze. A pbGC treatment may be preferred for patients with GO in the active or congestive phase before OD considering the IOP.Copyright © 2024 by Mutaz B. Habal, MD.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 4 区医学

小类 | 4 区外科

最新[2025]版：

大类 | 4 区医学

小类 | 4 区外科

第一作者：

第一作者机构： [1]Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing.

通讯作者：

通讯机构： [1]Department of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing. [2]Aier Eye Hospital Group Co., Ltd, Beijing Aier Eye Hospital, Beijing, Jinan University, Guangzhou, Guangdong, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy [2]三种眼压计测量眼压的对比研究 [3]Rapamycin improves Graves' orbitopathy by suppressing CD4+cytotoxic T lymphocytes [4]Severity Identification of Graves Orbitopathy via Random Forest Algorithm [5]Rapamycin Plus Methylprednisolone Versus Methylprednisolone Alone in Active, Moderate-to-severe Graves' Orbitopathy. [6]ICARE回弹式眼压计在婴幼儿青光眼的临床应用 [7]Valsalva Maneuver, Intraocular Pressure, Cerebrospinal Fluid Pressure, and Optic Disc Topography: Beijing Intracranial and Intraocular Pressure (iCOP) Study [8]Preliminary evidence of the association between DNAm and orbital volumetry in GO [9]The value of SPECT/CT imaging of lacrimal glands as a means of assessing the activity of Graves' orbitopathy [10]Using the Random Forest Algorithm to Detect the Activity of Graves Orbitopathy